Oxiracetam

Oxiracetam
Clinical data
Routes of
administration		Oral, IV
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: Unscheduled
Pharmacokinetic data
Bioavailability56-82%
Onset of action30-90 Minutes
Elimination half-life8 hours
ExcretionRenal
Identifiers
  • (RS)-2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.164.173
Chemical and physical data
FormulaC6H10N2O3
Molar mass158.157 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=C(N)CN1C(=O)CC(O)C1
  • InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10) Y
  • Key:IHLAQQPQKRMGSS-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Oxiracetam (developmental code name ISF 2522) is a nootropic drug of the racetam family and a very mild stimulant. Several studies suggest that the substance is safe even when high doses are consumed for a long period of time. However, the mechanism of action of the racetam drug family is still a matter of research. Oxiracetam is not approved by Food and Drug Administration for any medical use in the United States.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.